Studies related to Metabolic Rate and Chromium

Chromium Picolinate Supplementation Attenuates Body Weight Gain And Increases Insulin Sensitivity In Subjects With Type 2 Diabetes

Effect None
Trial Design Cohort
Trial Length 6+ Months
Number of Subjects 25
Sex Both Genders
Age Range 45-64
Body Types Obese
Notes for this study:
Supplementation of 1,000µg chromium (as picolinate) alongside sulfonylurea therapy for 10 months in type II diabetic persons noted that, relative to a sulfonylurea/placebo pairing, that chromium resulted in an additional decrease in glucose and free fatty acids in serum without any other significant alterations.

There appeared to be an anti-obese effect of chromium, as the 0.9kg weight gain with sulfonylurea therapy was mitigated with chromium coingestion.